alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 653.3 Risk management. ( a ) *Risk management program.* The Corporation's board of directors must establish, maintain, and periodically update an enterprise-wide risk management program addressing how the Corporation's activities are exercised in a safe and sound manner. The implementation of the risk management program may reside with senior management. The risk management program at a minimum must: ( 1 ) Periodically assess and document the Corporation's risk profile.
( 2 ) Align the Corporation's risk profile with the board-approved risk appetite and the Corporation's operational planning strategies and objectives.
( 3 ) Specify management's authority to carry out risk management responsibilities.
( 4 ) Integrate risk management and control objectives into management goals and compensation structures.
( 5 ) Comply with all applicable FCA regulations and policies.
( b ) *Risk committee.* The Corporation's board-level risk committee assists the full board of directors in the oversight of the enterprise-wide risk management program of the Corporation. ( 1 ) The risk committee must have at least one member with an understanding of risk management commensurate with the Corporation's capital structure, risk profile, complexity, activities, size, and other appropriate risk-related factors.
( 2 ) The responsibilities of the risk committee include, but are not limited to: ( i ) Periodically assessing management's implementation of the enterprise-wide risk management program;
( ii ) Recommending changes to the risk management program to keep the program commensurate with the Corporation's capital structure, risk appetite, complexity, activities, size, and other appropriate risk-related factors; and
( iii ) Receiving and reviewing regular reports directly from personnel responsible for implementing the Corporation's risk management program.
( c ) *Management of risk.* The Corporation must have a risk officer, however styled, who is responsible for implementing and maintaining the enterprise-wide risk management practices of the Corporation. The risk officer must have risk management experience commensurate with the Corporation's capital structure, risk appetite, complexity, activities, and size. The responsibilities of the risk officer include, but are not limited to: ( 1 ) Identifying and monitoring compliance with risk limits, exposures, and controls;
( 2 ) Implementing risk management policies, procedures, and risk controls;
( 3 ) Developing appropriate processes and systems for identifying and reporting risks, including emerging risks;
( 4 ) Reporting on risk management issues, emerging risks, and compliance concerns; and
( 5 ) Making recommendations on adjustments to the risk management policies, procedures, and risk controls of the Corporation.
§ 44.1 Authority, purpose, scope, and relationship to other authorities. ( a ) *Authority.* This part is issued by the OCC under section 13 of the Bank Holding Company Act of 1956, as amended (12 U.S.C. 1851).
( b ) *Purpose.* Section 13 of the Bank Holding Company Act establishes prohibitions and restrictions on proprietary trading and on investments in or relationships with covered funds by certain banking entities, including national banks, Federal branches and agencies of foreign banks, Federal savings associations, and certain subsidiaries thereof. This part implements section 13 of the Bank Holding Company Act by defining terms used in the statute and related terms, establishing prohibitions and restrictions on proprietary trading and on investments in or relationships with covered funds, and explaining the statute's requirements.
( c ) *Scope.* This part implements section 13 of the Bank Holding Company Act with respect to banking entities for which the OCC is authorized to issue regulations under section 13(b)(2) of the Bank Holding Company Act (12 U.S.C. 1851(b)(2)) and take actions under section 13(e) of that Act (12 U.S.C. 1851(e)). These include national banks, Federal branches and Federal agencies of foreign banks, Federal savings associations, Federal savings banks, and any of their respective subsidiaries (except a subsidiary for which there is a different primary financial regulatory agency, as that term is defined in this part), but do not include such entities to the extent they are not within the definition of banking entity in § 44.2(c).
( d ) *Relationship to other authorities.* Except as otherwise provided under section 13 of the Bank Holding Company Act or this part, and notwithstanding any other provision of law, the prohibitions and restrictions under section 13 of the Bank Holding Company Act and this part shall apply to the activities and investments of a banking entity identified in paragraph (c) of this section, even if such activities and investments are authorized for the banking entity under other applicable provisions of law.
( e ) *Preservation of authority.* Nothing in this part limits in any way the authority of the OCC to impose on a banking entity identified in paragraph (c) of this section additional requirements or restrictions with respect to any activity, investment, or relationship covered under section 13 of the Bank Holding Company Act or this part, or additional penalties for violation of this part provided under any other applicable provision of law.
[79 FR 5804, Jan. 31, 2014, as amended at 84 FR 35019, July 22, 2019]
#### § 313.40 Scope.

These salary offset regulations are issued in compliance with 5 U.S.C. 5514 and 5 CFR part 550, subpart K, and apply to the collection of debts owed by employees of the FDIC or other federal agencies. These salary offset procedures do not apply where an employee consents to the recovery of a debt from his current pay account. These procedures do not apply to debts arising under the Internal Revenue Code, the tariff laws of the United States or to any case where collection of a debt by salary offset is explicitly provided for or prohibited by another statute (e.g., travel advances under 5 U.S.C. 5705 and employee training expenses under 5 U.S.C. 4108). These procedures do not preclude an employee from requesting waiver of an erroneous payment under 5 U.S.C. 5584, or in any way questioning the amount or validity of a debt, in the manner specified by law or these agency regulations. This section also does not preclude an employee from requesting waiver of the collection of a debt under any other applicable statutory authority. When possible, salary offset through centralized administrative offset procedures should be attempted before seeking salary offset from a paying agency different than the creditor agency.
#### § 390.430 Filing of copies of offering circulars in certain exempt offerings.

A copy of the offering circular, or similar document, if any, used in connection with an offering exempt from the offering circular requirement of § 390.411 by reason of § 390.412(e) or § 390.413 shall be mailed to the FDIC within 30 days after the first sale of such securities. Such copy of the offering circular, or similar document, is solely for the information of the FDIC and shall not be deemed to be “filed” with the FDIC pursuant to § 390.411. The mailing to the FDIC of such offering circular, or similar document, shall not be a pre-condition of the applicable exemption from the offering circular requirements of § 390.411.
§ 615.5570 Book-entry procedures for Federal Agricultural Mortgage Corporation Securities. ( a ) The Federal Agricultural Mortgage Corporation (Farmer Mac) is a Federally chartered instrumentality of the United States and an institution of the Farm Credit System, subject to the examination and regulation of the Farm Credit Administration.
( b ) Farmer Mac, either in its own name or through an affiliate controlled or owned by Farmer Mac, is authorized by section 8.6 of the Act: ( 1 ) To issue and/or guarantee the timely payment of principal and interest on securities representing interests in or obligations backed by pools of agricultural real estate loans (guaranteed securities); and
( 2 ) To issue debt obligations (which, together with the guaranteed securities described in paragraph (b)(1) of this section, are referred to as Farmer Mac securities). Farmer Mac may prescribe the forms, the denominations, the rates of interest, the conditions, the manner of issuance, and the prices of Farmer Mac securities.
( c ) Farmer Mac securities shall be governed by §§ 615.5450, and 615.5452 through 615.5460. In interpreting those sections for purposes of this subpart, unless the context requires otherwise, the term “Farmer Mac securities” shall be read for “Farm Credit securities,” and “Farmer Mac” shall be read for “Farm Credit banks” and “Funding Corporation.” These terms shall be read as though modified where necessary to effectuate the application of the designated sections of subpart O of this part to Farmer Mac.
[61 FR 31394, June 20, 1996, as amended at 61 FR 67195, Dec. 20, 1996]
Exhibit 32.1




CERTIFICATION
PURSUANT TO


SECTION
1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002




In
connection with the Quarterly Report of Theragenics Corporation, (the “Company”)
on Form 10-Q for the period ended June 29, 2008 as filed with the Securities and
Exchange Commission on the date hereof (the “Report”), I, M. Christine Jacobs,
President and Chief Executive Officer, certify pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:





(1)
            The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934; and(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the Company
      as of the dates and for the periods referred to in the
    Report.






Date: August
      7, 2008
            By:
            /s/ M.
      Christine JacobsM.
      Christine JacobsChief
      Executive Officer








A signed
original of this written statement required by Section 906 has been provided to
Theragenics Corporation and will be retained by Theragenics Corporation and
furnished to the Securities and Exchange Commission or its staff upon
request.
§ 624.10 Documentation of margin matters. A covered swap entity shall execute trading documentation with each counterparty that is either a swap entity or financial end user regarding credit support arrangements that: ( a ) Provides the covered swap entity and its counterparty with the contractual right to collect and post initial margin and variation margin in such amounts, in such form, and under such circumstances as are required by this subpart, and at such time as initial margin or variation margin is required to be collected or posted under § 624.3 or § 624.4, as applicable; and
( b ) Specifies: ( 1 ) The methods, procedures, rules, and inputs for determining the value of each non-cleared swap or non-cleared security-based swap for purposes of calculating variation margin requirements; and
( 2 ) The procedures by which any disputes concerning the valuation of non-cleared swaps or non-cleared security-based swaps, or the valuation of assets collected or posted as initial margin or variation margin, may be resolved; and
( c ) Describes the methods, procedures, rules, and inputs used to calculate initial margin for non-cleared swaps and non-cleared security based swaps entered into between the covered swap entity and the counterparty.
[80 FR 74898, 74913, Nov. 30, 2015, as amended at 85 FR 39777, July 1, 2020]
#### Frank Robinson, Plaintiff, *v.*The Ecuador Development Co., Defendant.

(Supreme Court, Kings Special Term,

June, 1900.)

Verification — By “ agent ” of foreign corporation — Code C. P., §§ 525, 526.

An officer of a foreign corporation is an “ agent * * * for the party” within the meaning of section 525 of the Code of Civil Procedure, and, therefore, may verify a pleading for the corporation, but, in so doing, must comply with section 526 of the said Code and “ set forth in the affidavit the grounds of his belief as to all matters not stated upon his knowledge He need not state “ the reason why it is not made by the party ”, as a corporation cannot take an oath.

*107Motion to compel the plaintiff to accept service of an answer, which was returned on the stated ground that it was not properly verified for the defendant, a foreign corporation, in that the secretary of the defendant, who verified it, did not set forth in his affidavit of verification the grounds of bis belief as to the matters stated on information and belief in the answer.

George D. Mumford for plaintiff.

Sherrill *&*Lockwood for defendant.

Gaynor, J.:

Section 525 of the Code of Civil Procedure provides that the verification of a pleading “ must ” be made by a “ party ”, “ except ” (only what is applicable being here cited) that where the “ party ” is a domestic corporation it “ must ” be made by an officer thereof, and that where a foreign corporation it “ may ” be made by “ the agent of or the attorney for the party ”. This terminology shows that an “ officer ” of a corporation party is not to be deemed a “party”. If otherwise, this distinction between a corporation “ party ” and its “ officer ” would be a contradiction of terms. An officer of a foreign corporation is an agent thereof in law, and within the meaning of the Code provision. The secretary of this corporation can therefore verify this answer; but to do so he must comply with section 526, i. e. “ set forth in the affidavit the grounds of his belief as to all matters not stated upon his knowledge.” He need not set forth “ the reason why it is not made by the party”, for that would be senseless in the case of a corporation, which cannot take an oath. It would be useless to refer to the contradictory decisions under the former Code of Procedure on this subject of verification of pleadings.

The motion is denied; but with leave to the defendant to serve a properly verified answer within five days on payment of $10 costs.
<PAGE>

                                                                    EXHIBIT 99.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Annual Report of Bell Microproducts, Inc. (the
"Company") on Form 10-K for the year ended December 31, 2002 as filed with the
Securities and Exchange Commission (the "Report"), I, James E. Illson, Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section.1350,
as adopted pursuant to Section.906 of the Sarbanes-Oxley Act of 2002, that:

         (1)      The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in
all material respects, the financial condition and results of operations of the
Company.

         Dated:  March 31, 2003

                                                /s/ James E. Illson
                                                -------------------------------
                                                Chief Financial Officer
**Exhibit31.4**

**CERTIFICATION**

 

I, Michael D. Casey, certify that:

 

1.               I have reviewed this quarterly report on Form10-Q of The William Carter Company;

 

2.               Based on my knowledge, this report does notcontain any untrue statement of a material fact or omit to state a materialfact necessary to make the statements made, in light of the circumstances underwhich such statements were made, not misleading with respect to the periodcovered by this report;

 

3.               Based on my knowledge, the financialstatements, and other financial information included in this report, fairlypresent in all material respects the financial condition, results of operationsand cash flows of the registrant as of, and for, the periods presented in thisreport;

 

4.               The registrant’s other certifying officers andI are responsible for establishing and maintaining disclosure controls andprocedures (as defined in Exchange Act Rules 13a-15(e) and 15(d)-15(e)) for theregistrant and have:

 

(a) Designed such disclosure controls andprocedures, or caused such disclosure controls and procedures to be designedunder our supervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made known to us byothers within those entities, particularly during the period in which thisreport is being prepared;

 

(b) Evaluated the effectiveness of theregistrant’s disclosure controls and procedures and presented in this reportour conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on suchevaluation; and

 

(c) Disclosed in this report any change in theregistrant’s internal control over financial reporting that occurred during theregistrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarterin the case of an annual report) that has materially affected, or is reasonablylikely to materially affect, the registrant’s internal control over financialreporting; and

 

5.               The registrant’s other certifying officer(s)and I have disclosed, based on our most recent evaluation of internal controlover financial reporting, to the registrant’s auditors and the audit committeeof the registrant’s board of directors (or persons performing the equivalentfunctions):

 

(a) All significant deficiencies and materialweaknesses in the design or operation of internal control over financialreporting which are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, thatinvolves management or other employees who have a significant role in theregistrant’s internal control over financial reporting.

 
| Date: August 17, 2004 |                      |     |
|-----------------------|---------------------------|----------|
|                  |                      |     |
|                  | /s/ MICHAEL D. CASEY      |     |
|                  | Michael D. Casey          |     |
| * *              | *Chief Financial Officer* | * * |

#### * *

 

----
§ 308.134 Scope. The rules and procedures in this subpart, subpart B of the Local Rules and the Uniform Rules shall apply to proceedings by the Board of Directors or its designee: ( a ) To censure, limit the activities of, suspend, or revoke the registration of, any municipal securities dealer for which the FDIC is the appropriate regulatory agency;
( b ) To censure, suspend, or bar from being associated with such a municipal securities dealer, any person associated with such a municipal securities dealer; and
( c ) To deny registration, to censure limit the activities of, suspend, or revoke the registration of, any transfer agent or clearing agency for which the FDIC is the appropriate regulatory agency. This subpart and the Uniform Rules shall not apply to proceedings to postpone or suspend registration of a transfer agent or clearing agency pending final determination of denial or revocation of registration.
[Federal Register Volume 74, Number 198 (Thursday, October 15, 2009)]
[Notices]
[Page 52981]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-24817]



[[Page 52981]]

-----------------------------------------------------------------------

NATIONAL SCIENCE FOUNDATION


Proposal Review Panel for Physics; Notice of Meeting

    In accordance with the Federal Advisory Committee Act (Pub. L. 92-
463, as amended), the National Science Foundation announces the 
following meeting.

    Name: Rutgers University Site Visit (1208).
    Date and Time: Tuesday, October 27, 2009; 8 a.m.-5 p.m. 
Wednesday, October 28, 2009; 8 a.m.-1 p.m.
    Place: Rutgers University, Piscataway, NJ.
    Type of Meeting: Partially Closed.
    Contact Person: Dr. James Reidy, Program Director for Elementary 
Particle Physics, National Science Foundation, 4201 Wilson Blvd., 
Arlington, VA 22230. Telephone: (703) 292-7392.
    Purpose of Meeting: To provide an evaluation concerning the 
proposal submitted to the National Science Foundation.
    Agenda:

Tuesday, October, 27, 2009

Open: 0800-0930--Orientation, Introduction of Panel, Welcome; 0930-
1145--Tevatron presentations.
Closed: 1145-0100--Meeting with the Department Chair, Dean, and 
Students; 0100-0130--Executive Session.
Open: 0130-0230--CMS--M&O/PLT presentations; 0245-0300--Computing 
and Networks; 0315-0415--CMS and Facilities Tour.
Closed: 0415-0600--Executive Session.

Wednesday, October 27, 2009

Open: 0745-1015--CMS Physics Presentations.
Closed: 1015-0100--Executive Session.
    Reason for Closing: The proposal contains proprietary or 
confidential material, including technical information on personnel. 
These matters are exempt under 5 U.S.C. 552b(c)(2)(4) and (6) of the 
Government in the Sunshine Act.


    Dated: October 9, 2009.
Susanne Bolton,
Committee Management Officer.
[FR Doc. E9-24817 Filed 10-14-09; 8:45 am]
BILLING CODE 7555-01-P
Exhibit 12.1
  1.
    
    I have reviewed this annual report on Form 20-F of Natuzzi S.p.A.;
 2.
    
    Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this report;
 3.
    
    Based on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the company as of, and for, the periods presented
in this report;
 4.
    
    The companys other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the company and have:
     5.
    
    The companys other certifying officer(s) and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the companys auditors
and the audit committee of the companys board of directors (or persons performing the
equivalent functions):
    /s/ Pasquale NatuzziName:
    
    Pasquale NatuzziTitle:
    
    Chief Executive Officer
UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q/A

(Amendment No. 1 to Form 10-Q)
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE         SECURITIES EXCHANGE ACT OF 1934           For the quarterly period ended March 31, 2002

OR

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE         SECURITIES EXCHANGE ACT OF 1934           FOR THE TRANSITION PERIOD FROM _________ TO _________

COMMISSION FILE NO. 0-15443
THERAGENICS CORPORATION®
(Exact name of registrant as specified in its charter)
Delaware58-1528626(State of incorporation)(I.R.S. Employer Identification Number)5203 Bristol Industrial Way  Buford, Georgia                     30518(Address of principal executive offices)                     (Zip Code)